[go: up one dir, main page]

US20100015285A1 - Process of preparing direct-acidified milk beverage keeping high viable cell count at ambient temperature - Google Patents

Process of preparing direct-acidified milk beverage keeping high viable cell count at ambient temperature Download PDF

Info

Publication number
US20100015285A1
US20100015285A1 US12/564,744 US56474409A US2010015285A1 US 20100015285 A1 US20100015285 A1 US 20100015285A1 US 56474409 A US56474409 A US 56474409A US 2010015285 A1 US2010015285 A1 US 2010015285A1
Authority
US
United States
Prior art keywords
milk beverage
process according
cell count
viable cell
ambient temperature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/564,744
Inventor
Haibo Ling
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BEIJING YIHECUN TECH Co Ltd
BEIJING YIHECUN Tech Co Ltd A CHINESE Corp
Original Assignee
BEIJING YIHECUN Tech Co Ltd A CHINESE Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BEIJING YIHECUN Tech Co Ltd A CHINESE Corp filed Critical BEIJING YIHECUN Tech Co Ltd A CHINESE Corp
Assigned to BEIJING YIHECUN TECH. CO., LTD. reassignment BEIJING YIHECUN TECH. CO., LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LING, HAIBO
Publication of US20100015285A1 publication Critical patent/US20100015285A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/11Lactobacillus
    • A23V2400/175Rhamnosus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus

Definitions

  • the invention relates to milk beverage field, in particular, a process of preparing direct-acidified milk beverage keeping high viable cell count at ambient temperature.
  • Direct-acidified milk beverage is highly appreciated by consumers especially children and women because of its smooth, sweet and sour taste.
  • acidulants, sweeters, flavourings, thickening and emulsifying stabilizers are added and mixed together to obtain acidified milk beverage containing more than 1.0% protein, and after being sterilized, its shelf life can reach to 3-6 months. Since such products are not fermented by lactic acid bacteria, the nutrition value is not high.
  • lactobacillus it is desirable for the manufactory of acidified milk beverage that viable lactobacillus can be added into direct-acidified milk beverage and kept viable for long time without negative influence to its taste.
  • lactobacillus it will metabolize lactose to produce lactic acid, thereby make the mouthfeel of product unacceptable to consumers.
  • the activity of lactobacillus is decreased gradually; by the end viable cell count can not be measured. And ambient temperature environment will speed up the process greatly.
  • Lactobacillus rhamnosus (available from American Type Culture Collection, bacterial strain number: ATCC 53103 ) is a probiotic strain isolated from healthy human body (U.S. Pat. No. 4,839,281; U.S. Pat. No. 5,032,399), and it can get rid of endotoxin from blood plasma (U.S. Pat. No. 5,413,785).
  • the distinctive character of this bacterium is that it does not metabolize lactose and is resistant to acid and oxygen. Since this bacterium has the function of prevention and treatment of stomach upset (such as diarrhea) and improvement of immunity, it is used in healthy and functional products (such as yoghourt).
  • One aspect of the invention is to provide a process of preparing direct-acidified milk beverage keeping high viable cell count at ambient temperature.
  • the process according to an embodiment of the invention includes: according to the characters of Lactobacillus rhamnosus ATCC 53103 that it can not metabolize lactose to produce lactic acid and can survive for a long time, adding this bacterium into direct-acidified milk beverage under aseptic conditions, meanwhile adding 0.01-5% wt of growth promoting factors, thereby obtaining direct-acidified milk beverage keeping high viable cell count at ambient temperature during storage.
  • ambient temperature refers to a temperature which can be reached indoor under normal conditions, such as 0-40° C., preferably 10-30° C.
  • milk is directly acidified to pH value 4.0-4.5 without fermentation, so as to obtain acidified milk beverage. Then sterilize and add concentrated culture, concentrated frozen culture or freeze dried culture of Lactobacillus rhamnosus ATCC 53103 together with 0.01-3% wt of growth promoting factors under aseptic condition.
  • said milk beverage is made from fresh milk or reconstituted milk (including but not limited to fresh milk or reconstituted milk of cow milk or goat milk).
  • the protein concentration of the milk beverage is 0.1-4%.
  • the protein concentration of the milk beverage is 0.7-2.5%.
  • the acidulants for adjusting pH value can be any acidulants which are known by people skilled in the art, such as one or more of citric acid, lactic acid and malic acid.
  • the pH value of finished product of direct-acidified milk beverage is 3.5-4.8, preferably 3.7-4.4.
  • the addition amount of Lactobacillus rhamnosus ATCC 53103 is not limited theoretically. According to the principle of economy and effectiveness, the addition amount of Lactobacillus rhamnosus ATCC 53103 is 10 3 -10 8 cfu/ml milk beverage, preferably 10 4 -10 7 cfu/ml milk beverage.
  • growth promoting factors can be any growth promoting ingredients known by people skilled in the art that can be utilized by Lactobacillus rhamnosus except lactose.
  • said growth promoting factors can be selected from one or more of glucose, fructose, galactose, arabinose, ribose, mannose, rhamnose, fucose, tagatose, sucrose, maltose, cellobiose, trehalose, melizitose, gentiobiose, galactitol, mannitol, sorbitol, inositol, gluconic acid, salicin, aescine, arbutin, amygdalin and acetylglucosamine, and the addition amount is 0.01-5% wt. It can be added together with milk base before sterilization or with Lactobacillus rhamnosus ATCC 53103 after sterilization under as
  • the growth promoting factors are selected from one or more of glucose, fructose, galactose and sucrose, the addition amount is 0.05-3% wt.
  • Sweeters, flavorings, stabilizers and preservatives can also be added into the above-mentioned direct-acidfied milk beverage.
  • sweeters can be selected from one or more of aspartame, Acesulfame-K (Ace-K), Sodium cyclamate, stevia sugar (stevioside) and Trichlorosucrose. And the addition amount can be 0.001-5 g/L, preferably 0.1-1 g/L.
  • Flavourings can be selected as seasoners, and the addition amount can be 0.001-5 g/L, preferably 0.1-1 g/L.
  • Stabilizers are selected from one or more of pectin, gelatin, modified starch, glyceryl monostearate, sucrose esters and sodium carboxymethyl Cellulose, and the addition amount can be 0.001-12 g/L, preferably 0.1-10 g/L.
  • Preservatives are selected from one or more of natamycin and potassium sorbate. And the addition amount is 0.001-3 g/L, preferably 0.005-0.5 g/L.
  • the direct-acidified milk beverage prepared by the process according to an embodiment of the invention can be stored for 1-6 months under room temperature (10-30° C.) and keep viable cell count at least 105 cfu/ml milk beverage.
  • the indexes of storage period and viable cell count are much higher than fermented milk beverage prepared by conventional process. Thereby the defects that directed-acidified milk beverage has no viable Lactobacillus and has low nutritional value are overcome.
  • Example 2 With the same process in Example 1, make reconstituted whole milk with 4.5% whole milk powder, and acidify it. Adjust the pH value of the mixture to 4.0 with 10% lactic acid. Homogenize and sterilize, then cool it down to below 37° C., add Lactobacillus rhamnosus ATCC 53103 (freeze dried culture powder) with quantity of 2 ⁇ 10 6 cfu/ml and 0.15% galactose into above-mentioned milk beverage aseptically, store it at 12-25° C. Measure its acidity and viable cell count during storage. The results are listed in table 3
  • Example 2 With the same process in Example 1, make reconstituted whole milk with 7% whole milk powder, and acidify it. Adjust the pH value of the mixture to 4.4 with 10% malic acid. Homogenize and sterilize, then cool it down to below 37° C., add Lactobacillus rhamnosus ATCC 53103 ( concentrated frozen culture) with quantity of 2 ⁇ 10 7 cfu/ml and 0.02% fructose into above-mentioned milk beverage aseptically, store it at 12-25° C. Measure the pH value and viable cell count during storage. The results are listed in table 4.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Dairy Products (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Non-Alcoholic Beverages (AREA)

Abstract

The invention provides a process of preparing direct-acidified milk beverage keeping high viable cell count at ambient temperature. The process means that, adopting conventional technology to prepare acidified milk beverage and sterilizing, then adding Lactobacillus rhamnosus ATCC 53103 and certain quantity of growth promoting factors under aseptic condition. According to various pH value, the product can be stored at ambient temperature for 1-6 months and the viable cell count will not be less than 105 cfu/ml milk beverage. The indexes of storage period and viable cell count are much higher than fermented milk beverage prepared by conventional process. Thereby it overcomes the defects that direct-acidified milk beverage with long shelf life has no viable lactic acid bacteria and has low nutritional value.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation-in-part of international application No. PCT/CN2007/002035 filed on Jun. 29, 2007, which claims the priority benefits of China application No. 200710064896.X filed on Mar. 28, 2007. The contents of these prior applications are hereby incorporated by reference in its entirety.
  • TECHNICAL FIELD
  • The invention relates to milk beverage field, in particular, a process of preparing direct-acidified milk beverage keeping high viable cell count at ambient temperature.
  • TECHNICAL BACKGROUND
  • Direct-acidified milk beverage is highly appreciated by consumers especially children and women because of its smooth, sweet and sour taste. Using milk as base, acidulants, sweeters, flavourings, thickening and emulsifying stabilizers are added and mixed together to obtain acidified milk beverage containing more than 1.0% protein, and after being sterilized, its shelf life can reach to 3-6 months. Since such products are not fermented by lactic acid bacteria, the nutrition value is not high.
  • It is desirable for the manufactory of acidified milk beverage that viable lactobacillus can be added into direct-acidified milk beverage and kept viable for long time without negative influence to its taste. However, up to now, no relevant technology has been reported. Usually when lactobacillus is added into milk, they will metabolize lactose to produce lactic acid, thereby make the mouthfeel of product unacceptable to consumers. Meanwhile, the activity of lactobacillus is decreased gradually; by the end viable cell count can not be measured. And ambient temperature environment will speed up the process greatly.
  • Some documents have reported processes for increasing the viable cell count of lactobacillus. These processes include: adding antioxidant (such as VC), adding prebiotics(such as oligosaccharides), encapsulating lactobacillus into microcapsule, non-adding Lactobacillus bulgaricus and decreasing oxidation-reduction potential (such as adding cysteine) etc . . . (NP. Shah, Probiotic bacteria: Selective enumeration and survival in dairy foods, J. Dairy Sci., 83:894-907, 2000; A. Lourensand B. C. Vijoen Int. Dairy J., 11: 1-17, 2001). However, the effect of these processes is very limited.
  • Lactobacillus rhamnosus (available from American Type Culture Collection, bacterial strain number: ATCC 53103 ) is a probiotic strain isolated from healthy human body (U.S. Pat. No. 4,839,281; U.S. Pat. No. 5,032,399), and it can get rid of endotoxin from blood plasma (U.S. Pat. No. 5,413,785). The distinctive character of this bacterium is that it does not metabolize lactose and is resistant to acid and oxygen. Since this bacterium has the function of prevention and treatment of stomach upset (such as diarrhea) and improvement of immunity, it is used in healthy and functional products (such as yoghourt). The details of the biological characteristics and probiotic function of this bacterium please refer to above-mentioned patents and review article M. Saxelin, Lactobacillus GG A human probiotic strain with thorough clinical documentation, Food Rev. Int., 13 :293-313, 1997.
  • SUMMARY OF INVENTION Technical Problem to Be Solved
  • One aspect of the invention is to provide a process of preparing direct-acidified milk beverage keeping high viable cell count at ambient temperature.
  • Technical Solutions
  • The process according to an embodiment of the invention includes: according to the characters of Lactobacillus rhamnosus ATCC 53103 that it can not metabolize lactose to produce lactic acid and can survive for a long time, adding this bacterium into direct-acidified milk beverage under aseptic conditions, meanwhile adding 0.01-5% wt of growth promoting factors, thereby obtaining direct-acidified milk beverage keeping high viable cell count at ambient temperature during storage.
  • The term “ambient temperature” herein refers to a temperature which can be reached indoor under normal conditions, such as 0-40° C., preferably 10-30° C.
  • In the process according to an embodiment of the invention, milk is directly acidified to pH value 4.0-4.5 without fermentation, so as to obtain acidified milk beverage. Then sterilize and add concentrated culture, concentrated frozen culture or freeze dried culture of Lactobacillus rhamnosus ATCC 53103 together with 0.01-3% wt of growth promoting factors under aseptic condition.
  • Wherein, said milk beverage is made from fresh milk or reconstituted milk (including but not limited to fresh milk or reconstituted milk of cow milk or goat milk). The protein concentration of the milk beverage is 0.1-4%. Preferably, the protein concentration of the milk beverage is 0.7-2.5%.
  • In the process according to an embodiment of the invention, the acidulants for adjusting pH value can be any acidulants which are known by people skilled in the art, such as one or more of citric acid, lactic acid and malic acid.
  • The pH value of finished product of direct-acidified milk beverage is 3.5-4.8, preferably 3.7-4.4.
  • In the process according to an embodiment of the invention, the addition amount of Lactobacillus rhamnosus ATCC 53103 is not limited theoretically. According to the principle of economy and effectiveness, the addition amount of Lactobacillus rhamnosus ATCC 53103 is 103-108cfu/ml milk beverage, preferably 104-107 cfu/ml milk beverage.
  • In the process according to an embodiment of the invention, above-mentioned growth promoting factors can be any growth promoting ingredients known by people skilled in the art that can be utilized by Lactobacillus rhamnosus except lactose. Preferably, said growth promoting factors can be selected from one or more of glucose, fructose, galactose, arabinose, ribose, mannose, rhamnose, fucose, tagatose, sucrose, maltose, cellobiose, trehalose, melizitose, gentiobiose, galactitol, mannitol, sorbitol, inositol, gluconic acid, salicin, aescine, arbutin, amygdalin and acetylglucosamine, and the addition amount is 0.01-5% wt. It can be added together with milk base before sterilization or with Lactobacillus rhamnosus ATCC 53103 after sterilization under aseptic condition.
  • More preferably, the growth promoting factors are selected from one or more of glucose, fructose, galactose and sucrose, the addition amount is 0.05-3% wt.
  • Sweeters, flavorings, stabilizers and preservatives can also be added into the above-mentioned direct-acidfied milk beverage.
  • Wherein, sweeters can be selected from one or more of aspartame, Acesulfame-K (Ace-K), Sodium cyclamate, stevia sugar (stevioside) and Trichlorosucrose. And the addition amount can be 0.001-5 g/L, preferably 0.1-1 g/L.
  • Flavourings can be selected as seasoners, and the addition amount can be 0.001-5 g/L, preferably 0.1-1 g/L.
  • Stabilizers are selected from one or more of pectin, gelatin, modified starch, glyceryl monostearate, sucrose esters and sodium carboxymethyl Cellulose, and the addition amount can be 0.001-12 g/L, preferably 0.1-10 g/L.
  • Preservatives are selected from one or more of natamycin and potassium sorbate. And the addition amount is 0.001-3 g/L, preferably 0.005-0.5 g/L.
  • ADVANTAGEOUS EFFECTS
  • The direct-acidified milk beverage prepared by the process according to an embodiment of the invention can be stored for 1-6 months under room temperature (10-30° C.) and keep viable cell count at least 105 cfu/ml milk beverage. The indexes of storage period and viable cell count are much higher than fermented milk beverage prepared by conventional process. Thereby the defects that directed-acidified milk beverage has no viable Lactobacillus and has low nutritional value are overcome.
  • DESCRIPTION OF EMBODIMENTS
  • The following examples are used to illustrate the invention, but not to limit the scope of the invention.
  • EXAMPLE 1 Direct-Acidified Milk Beverage Prepared with Lactobacillus rhamnosus and its Storage Test
  • Add 3.5% whole milk powder into fresh milk containing 11.5% milk solid; thereby obtain whole milk with 15% milk solid. Use 700 ml of water at 70° C. to resolve acidic milk beverage stabilizer SY-601 (provide by BEIING FUMENGTE BIOTECHNOLOGY COMPANY LTD.) 6 g and Ace-K ( available from ZHANGJIAGUANG HAOBO CHEMISTRY COMPANY) 5 g, stir for 20 minutes and cool down to below 25° C. After hydration for 30 minutes, add 200 ml above mentioned reconstituted whole milk into 700 ml stabilizer solution and stir for 5 minutes. Adjust the pH value of the mixture to 4.5 with 10% citric acid, adjust the volume to 1000 ml with water, continue to stir for 5 minutes. Preheat to 70° C., then homogenize with pressure 20 MPa, then sterilize at 115° C. for 15 minutes. The above procedure is the conventional method to prepare direct acidified milk beverage which is known to people skilled in this field.
  • Cool it down to below 37° C., inoculate this acidified milk beverage with Lactobacillus rhamnosus ATCC 53103 ( concentrated culture) with quantity of 1.5×106 cfu/ml and 0.02% glucose aseptically. Keep the milk beverage at 37° C. for 15 days then 28° C. for 45 days, measure its pH value, acidity and viable cell count. The results are listed in table 1.
  • TABLE 1
    Viability of lactobacillus and the pH value & acidity variation of
    the acidified milk beverage during storage
    Viable cell
    Storage storage time Titratable count (×106/ml
    temperature (day) pH value acidity milk beverage)
    37° C. 0 4.50 35 1.5
    1 4.44 33 22
    3 4.47 35 16.7
    6 4.50 35 14.2
    9 4.53 31 3
    12 4.53 31 3.6
    15 4.54 30 3.6
    28° C. 18 4.57 28 2.5
    24 4.52 32 1.2
    27 4.57 28 1.6
    30 4.56 31 0.9
    37 4.56 31 1.1
    60 4.59 29 0.68
  • EXAMPLE 2 Direct-Acidified Milk Beverage Prepared with Lactobacillus rhamnosus and its Storage Test
  • Prepare reconstituted whole milk with 10% whole milk powder and make a mixture with 1.0% milk protein by the same process as in Example 1, adjust the pH value of the mixture to 4.2 with 10% lactic acid. Adding 0.1% glucose, 0.4% sucrose inside the mixture, homogenize and sterilize, then cool it down to below 37° C., add Lactobacillus rhamnosus ATCC 53103 (concentrated frozen culture) with quantity of 1.5×105 cfu/ml into above-mentioned acidified milk beverage, store it at 12-25° C. Measure the pH value and viable cell count in different storage period. The results are listed in table 2.
  • TABLE 2
    Viability of lactobacillus and pH value variation of the acidified
    milk beverage during storage
    Viable cell count
    storage (106 cfu/ml
    time (month) pH value milk beverage)
    0 4.2 2
    1 3.8 98
    2 3.82 34
    3 3.80 7.6
    4 3.85 2.1
    5 3.85 0.9
    6 3.83 0.25
  • EXAMPLE 3 Direct-Acidified Milk Beverage Prepared with Lactobacillus rhamnosus and its Storage Test
  • With the same process in Example 1, make reconstituted whole milk with 4.5% whole milk powder, and acidify it. Adjust the pH value of the mixture to 4.0 with 10% lactic acid. Homogenize and sterilize, then cool it down to below 37° C., add Lactobacillus rhamnosus ATCC 53103 (freeze dried culture powder) with quantity of 2×106 cfu/ml and 0.15% galactose into above-mentioned milk beverage aseptically, store it at 12-25° C. Measure its acidity and viable cell count during storage. The results are listed in table 3
  • TABLE 3
    Viability of lactobacillus and pH value variation of the acidified
    milk beverage during storage
    Viable cell count
    storage (106 cfu/ml
    time (month) pH value milk beverage)
    0 4.2 0.15
    1 4.1 210
    2 4.09 180
    3 4.11 110
    4 4.08 82
    5 4.07 32
    6 4.08 8.5
  • EXAMPLE 4 Direct-Acidified Milk Beverage Prepared with Lactobacillus rhamnosus and its Storage Test
  • With the same process in Example 1, make reconstituted whole milk with 7% whole milk powder, and acidify it. Adjust the pH value of the mixture to 4.4 with 10% malic acid. Homogenize and sterilize, then cool it down to below 37° C., add Lactobacillus rhamnosus ATCC 53103 ( concentrated frozen culture) with quantity of 2×107 cfu/ml and 0.02% fructose into above-mentioned milk beverage aseptically, store it at 12-25° C. Measure the pH value and viable cell count during storage. The results are listed in table 4.
  • TABLE 4
    Viability of lactobacillus and pH value variation of the acidified
    milk beverage during storage
    Viable cell count
    storage (106 cfu/ml
    time (month) pH value milk beverage)
    0 4.40 20
    1 4.30 245
    2 4.31 178
    3 4.30 105
    4 4.28 92
    5 4.35 65
    6 4.29 48

Claims (20)

1. A process of preparing direct-acidified milk beverage keeping high viable cell count at ambient temperature, wherein milk beverage is not through fermentation, directly by adjusting pH value to 4.0-4.5 to obtain acidified milk beverage, then sterilizing, adding concentrated culture, concentrated frozen culture or freeze dried culture of Lactobacillus rhamnosus ATCC 53103 together with 0.01-3% wt of growth promoting factors under aseptic condition.
2. The process according to claim 1, wherein said milk beverage is made from fresh milk or reconstituted milk, the protein concentration of the milk beverage is 0.1-4%;
3. The process according to claim 2, wherein the protein concentration of the milk beverage is 0.7-2.5%.
4. The process according to claim 1, wherein the acidulants for adjusting pH value are selected from one or more of citric acid, lactic acid and malic acid.
5. The process according to claim 1, wherein the pH value of the finished product of acidified milk beverage is 3.5-4.8.
6. The process according to claim 5, wherein the pH value of the finished product of acidified milk beverage is 3.7-4.4.
7. The process according to claim 1, wherein said addition amount of Lactobacillus rhamnosus ATCC 53103 is 103-108 cfu/ml milk beverage.
8. The process according to claim 7, wherein said addition amount of Lactobacillus rhamnosus ATCC 53103 is 104-107 cfu/ml milk beverage.
9. The process according to claim 1, wherein said growth promoting factors are selected from one or more of glucose, fructose, galactose, arabinose, ribose, mannose, rhamnose, fucose, tagatose, sucrose, maltose, cellobiose, trehalose, melizitose, gentiobiose, galactitol, mannitol, sorbitol, inositol, gluconic acid, salicin, aescine, arbutin, amygdalin and acetylglucosamine, the addition amount is 0.01-5%, and it can be added together with milk base before sterilization or with Lactobacillus rhamnosus ATCC 53103 under aseptic condition.
10. The process according to claim 9, wherein said growth promoting factor is selected from one or more of glucose, fructose, galactose, sucrose, and the addition amount is 0.05-3%.
11. A direct-acidified milk beverage keeping high viable cell count at ambient temperature prepared by the process according to claim 1.
12. A direct-acidified milk beverage keeping high viable cell count at ambient temperature prepared by the process according to claim 2.
13. A direct-acidified milk beverage keeping high viable cell count at ambient temperature prepared by the process according to claim 3.
14. A direct-acidified milk beverage keeping high viable cell count at ambient temperature prepared by the process according to claim 4.
15. A direct-acidified milk beverage keeping high viable cell count at ambient temperature prepared by the process according to claim 5.
16. A direct-acidified milk beverage keeping high viable cell count at ambient temperature prepared by the process according to claim 6.
17. A direct-acidified milk beverage keeping high viable cell count at ambient temperature prepared by the process according to claim 7.
18. A direct-acidified milk beverage keeping high viable cell count at ambient temperature prepared by the process according to claim 8.
19. A direct-acidified milk beverage keeping high viable cell count at ambient temperature prepared by the process according to claim 9.
20. A direct-acidified milk beverage keeping high viable cell count at ambient temperature prepared by the process according to claim 10.
US12/564,744 2007-03-28 2009-09-22 Process of preparing direct-acidified milk beverage keeping high viable cell count at ambient temperature Abandoned US20100015285A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN200710064896.X 2007-03-28
CN200710064896 2007-03-28
PCT/CN2007/002035 WO2008116355A1 (en) 2007-03-28 2007-06-29 A method for preparing ambient-stable direct-acidified milk beverage with high counts of viable lactic acid bacteria

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2007/002035 Continuation-In-Part WO2008116355A1 (en) 2007-03-28 2007-06-29 A method for preparing ambient-stable direct-acidified milk beverage with high counts of viable lactic acid bacteria

Publications (1)

Publication Number Publication Date
US20100015285A1 true US20100015285A1 (en) 2010-01-21

Family

ID=39788021

Family Applications (2)

Application Number Title Priority Date Filing Date
US12/564,744 Abandoned US20100015285A1 (en) 2007-03-28 2009-09-22 Process of preparing direct-acidified milk beverage keeping high viable cell count at ambient temperature
US12/564,762 Active 2029-10-20 US10072310B2 (en) 2007-03-28 2009-09-22 Process of preparing fermented milk beverage keeping high viable cell count at ambient temperature

Family Applications After (1)

Application Number Title Priority Date Filing Date
US12/564,762 Active 2029-10-20 US10072310B2 (en) 2007-03-28 2009-09-22 Process of preparing fermented milk beverage keeping high viable cell count at ambient temperature

Country Status (3)

Country Link
US (2) US20100015285A1 (en)
CN (3) CN101273736B (en)
WO (2) WO2008116355A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130259977A1 (en) * 2010-11-18 2013-10-03 Meiji Co., Ltd. Fermented milk with reduced sourness and method for producing same
US20160227828A1 (en) * 2015-02-05 2016-08-11 Abbott Laboratories Substantially clear nutritional liquids having improved sensory characteristics
WO2021048350A1 (en) 2019-09-12 2021-03-18 Chr. Hansen A/S Lactic acid bacteria for a heat-treated food product for storage at ambient temperature
US11606965B2 (en) 2016-05-11 2023-03-21 Chr. Hansen A/S Lactic acid bacteria for a heat-treated food product for storage at ambient temperature

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE533537C2 (en) * 2009-06-18 2010-10-19 Tetra Laval Holdings & Finance Method for making a yogurt-based product
CN101700061B (en) * 2009-10-28 2012-06-27 山东康智多生物科技有限公司 High-activity fermented milk beverage and preparation method thereof
CN101708018B (en) * 2009-12-14 2013-03-13 杭州味全食品有限公司 Lactobacillus-casei probiotics beverage and preparation method thereof
CN102618456B (en) * 2012-02-28 2013-08-21 江南大学 Lactobacillus rhamnosus capable of relieving chronic alcohol liver injury and application thereof
EP2825207B1 (en) * 2012-03-16 2020-08-19 The Johns Hopkins University Non-linear multiblock copolymer-drug conjugates for the delivery of active agents
KR101381794B1 (en) * 2012-04-10 2014-04-07 씨제이제일제당 (주) Synbiotic food composition containing tagatose and probiotic lactic acid bacteria
CN103564043A (en) * 2012-07-24 2014-02-12 内蒙古蒙牛乳业(集团)股份有限公司 Fermented milk containing lactobacillus rhamnosus
CN104957256A (en) * 2015-07-01 2015-10-07 新疆香格尔食品有限责任公司 Fermentation type double-protein milk beverage and preparation method thereof
EP3344749A1 (en) * 2015-08-31 2018-07-11 Chr. Hansen A/S Lactobacillus fermentum bacteria with antifungal activity
CN105230784A (en) * 2015-10-29 2016-01-13 光明乳业股份有限公司 Viable bacteria type room-temperature fermented milk beverage and preparation method of viable bacteria type room-temperature fermented milk beverage
CN105707648A (en) * 2016-01-29 2016-06-29 江苏微康生物科技有限公司 Anti-fungus biological protection agent and application thereof
CN106234891A (en) * 2016-02-05 2016-12-21 上海交大昂立股份有限公司 High-activity probiotics fermenting plant beverage that a kind of room temperature preserves and preparation method thereof
CN105961588A (en) * 2016-05-03 2016-09-28 新希望乳业控股有限公司 Probiotic lactobacillus rhamnosus fermented milk and preparation method thereof
CN105961589A (en) * 2016-05-17 2016-09-28 安徽新希望白帝乳业有限公司 Preparation method of brown set-style yogurt capable of resisting post-acidification
KR20180066828A (en) * 2016-12-09 2018-06-19 씨제이제일제당 (주) Fermented milk comprising saccharides comprising high content of allulose
CN109497136A (en) * 2017-09-14 2019-03-22 内蒙古蒙牛乳业(集团)股份有限公司 A kind of post-fermentation room temperature viable bacteria sour milk and preparation method thereof
CN110279117A (en) * 2018-03-19 2019-09-27 医迈霖科技公司 A kind of probiotics frozen dried food
CN108813592A (en) * 2018-06-13 2018-11-16 北京颐和村生物科技有限公司 A kind of preparation method for the vegetarian product that ferments
CN109548875A (en) * 2018-10-30 2019-04-02 徐州汇尔康食品有限公司 A kind of rich selenium germanium Lactic acid bacteria drink article formulations
CN111227035A (en) * 2018-11-28 2020-06-05 内蒙古伊利实业集团股份有限公司 Fermented milk containing probiotic composition and preparation method thereof
CN111248269A (en) * 2018-11-30 2020-06-09 内蒙古伊利实业集团股份有限公司 Lactobacillus rhamnosus-containing probiotic fermented milk and preparation method thereof
CN109527089B (en) * 2018-12-19 2022-01-18 扬州市扬大康源乳业有限公司 Probiotic fresh milk and preparation method thereof
CN109619180B (en) * 2018-12-30 2022-09-23 光明乳业股份有限公司 Viable bacteria type normal-temperature fermented milk and preparation method thereof
CN112167339A (en) * 2020-10-16 2021-01-05 光明乳业股份有限公司 Lactobacillus rhamnosus fermented milk and preparation method thereof
CN112715655B (en) * 2020-12-25 2022-11-04 光明乳业股份有限公司 Lactobacillus plantarum fermented milk powder and preparation method thereof
CN113121013B (en) * 2021-04-16 2023-06-27 无锡映川环境技术有限公司 Autotrophic denitrification filter material with active bacterial coating and preparation method thereof
CN113632840A (en) * 2021-08-12 2021-11-12 河北弗蒙特生物科技有限公司 Probiotic milk or milk-containing beverage with high viable count and preparation method thereof
CA3232198A1 (en) * 2021-10-04 2023-04-13 Hui Han Method for producing fermented milk products for ambient storage
CN114052081A (en) * 2021-11-22 2022-02-18 光明乳业股份有限公司 Normal-temperature live bacterium yoghourt and preparation method thereof
CN116762858B (en) * 2022-03-07 2025-09-19 内蒙古伊利实业集团股份有限公司 Preparation method of normal-temperature viable bacteria fermented milk
CN115152842A (en) * 2022-07-13 2022-10-11 光明乳业股份有限公司 Lactobacillus fermentum normal-temperature milk beverage and preparation method thereof
CN115281247A (en) * 2022-07-13 2022-11-04 光明乳业股份有限公司 Lactobacillus fermentum normal-temperature yogurt and preparation method thereof
CN115136986A (en) * 2022-07-13 2022-10-04 光明乳业股份有限公司 Lactobacillus fermentum solid beverage and preparation method thereof
CN115997822B (en) * 2022-12-21 2024-02-23 光明乳业股份有限公司 Lactobacillus reuteri normal-temperature yoghourt and preparation method thereof
CN115943995B (en) * 2022-12-21 2024-03-01 光明乳业股份有限公司 Lactobacillus reuteri normal-temperature milk beverage and preparation method thereof
AU2024256668A1 (en) 2023-04-20 2025-10-23 Chr. Hansen A/S Storage stable lacticaseibacillus rhamnosus
CN116508922A (en) * 2023-05-21 2023-08-01 江西蒙天乳业有限公司 Preparation method of normal-temperature lactobacillus
CN119464163B (en) * 2025-01-15 2025-07-01 山东捷晶生物科技有限公司 Lactobacillus rhamnosus Lr-Ca011, metagen and calcium product for promoting calcium absorption and nanoemulsion homogenization preparation method thereof

Citations (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4169854A (en) * 1977-05-12 1979-10-02 Merck & Co., Inc. Direct acidified yogurt
US4839281A (en) * 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
US5413785A (en) * 1993-01-27 1995-05-09 New England Deaconess Hospital Corp. Methodology employing lactobacillus GG for reduction of plasma endotoxin levels circulating in-vivo
US5709857A (en) * 1994-05-26 1998-01-20 Dibra S.P.A. Lactobacillus strains of human origin, their compositons and uses thereof
US6007808A (en) * 1995-06-23 1999-12-28 Dibra S.P.A. Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders
US6156320A (en) * 1993-02-05 2000-12-05 Harry Parsekian Fermented milk nutraceuticals
WO2001088510A2 (en) * 2000-05-18 2001-11-22 Argose, Inc. Pre-and post-processing of spectral data for calibration using multivariate analysis techniques
US20020028269A1 (en) * 2000-06-13 2002-03-07 Lipton, Division Of Conopco, Inc. Lactobacillus containing product
US6358521B1 (en) * 1993-02-05 2002-03-19 Harry Parsekian Fermented milk nutraceuticals
US6506380B1 (en) * 1995-06-14 2003-01-14 Valio Oy Methods of preventing or treating allergies
US6596530B1 (en) * 1999-06-24 2003-07-22 Meiji Dairies Corporation Strain of Lactobacillus gasseri
US20030147857A1 (en) * 2002-02-05 2003-08-07 Corpak Medsystems, Inc. Probiotic/prebiotic composition and delivery method
US20040067573A1 (en) * 2002-10-07 2004-04-08 Eamonn Connolly Selection and use of lactic acid bacteria for reducing inflammmation caused by helicobacter
US20040115773A1 (en) * 2001-01-30 2004-06-17 Fabrizio Arigoni Serpin in bifidobacteria
US6835376B1 (en) * 1999-03-11 2004-12-28 Nestec S.A. Lactobacillus paracasei strain for preventing diarrhea caused by pathogenic bacteria
US20050002874A1 (en) * 2003-01-29 2005-01-06 Bo Mollstam Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries
US6872565B2 (en) * 2003-01-29 2005-03-29 Biogaia Ab Product containing Lactobacillus reuteri strain ATTC PTA-4965 or PTA-4964 for inhibiting bacteria causing dental caries
US6926891B1 (en) * 1999-08-05 2005-08-09 Nestec S.A. Treatment of diarrhea with strains of Bifidobacterium longum
US6942849B2 (en) * 1998-08-12 2005-09-13 Nestec S.A. Incorporation of exogenous lactic bacteria into the oral microflora
US20060013806A1 (en) * 2000-06-20 2006-01-19 Erika Isolauri Probiotics in primary prevention of atopic diseases
US7029669B1 (en) * 1999-03-11 2006-04-18 Nestec S. A. Lactic acid bacteria strains capable of preventing diarrhoea
US20060165661A1 (en) * 2003-06-13 2006-07-27 N>V> Nutricia Pediocin-producing pediococci
US20070110849A1 (en) * 2003-06-23 2007-05-17 Marie-Christine Secretin Infant or follow-on formula
US20070123460A1 (en) * 2004-04-20 2007-05-31 The University Of Chicago Probiotic compounds from Lactobacillus GG and uses therefor
US20070269515A1 (en) * 2003-12-24 2007-11-22 Henriksen Kristian L Probiotic Tablet Formulations
US20080095752A1 (en) * 2006-10-20 2008-04-24 Win-Chin Chiang Method for extending the shelf-life of powdered nutritional formulations which contain viable probiotics
US20090274661A1 (en) * 2006-02-15 2009-11-05 Nestec S.A. Use of bifidobacterium longum for the prevention and treatment of inflammation
US20110020304A1 (en) * 2008-03-14 2011-01-27 Nestec S.A. Synbiotic mixture

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL41570A (en) * 1973-02-19 1976-02-29 For Ind Res Ltd Centre A method for manufacture of non-dairy yoghurt product
US4748025A (en) * 1986-02-24 1988-05-31 Rutgers, The State University Of New Jersey Novel cultured buttermilk compositions and method of preparation
CN1097095A (en) * 1993-07-07 1995-01-11 汪群 Fresh-keeping flavour sour milk product
CN1129522A (en) * 1995-02-21 1996-08-28 魏立华 Activated lactic acid bacteria milk
CN1160451C (en) * 2000-10-16 2004-08-04 鼎健生物科技食品股份有限公司 Rhamnose lactic acid bacteria strain and its use
FI109602B (en) * 2001-01-25 2002-09-13 Valio Oy Probiotkombination
CN1357269A (en) * 2001-12-21 2002-07-10 李道光 Active lactic acid bacteria beverage and its prepn
FI113057B (en) * 2002-11-04 2004-02-27 Valio Oy Use of Lactobacillus rhamnosus LGG deposited under ATCC 53103, Lactobacillus rhamnosus LC705, DSM 7061, and Propionibacterium freudenreichii PJS, DSM 7067 for preparing a product for inhibiting yeast
JP2007028920A (en) * 2005-07-22 2007-02-08 Japan Research & Development Association For New Functional Foods Fermented milk and method for producing the same
CN100484405C (en) * 2006-07-21 2009-05-06 华南理工大学 Method for preparing active lactic acid bacteria beverage

Patent Citations (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4169854A (en) * 1977-05-12 1979-10-02 Merck & Co., Inc. Direct acidified yogurt
US4839281A (en) * 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
US5032399A (en) * 1985-04-17 1991-07-16 Sherwood L. Gorbach L. acidophilus strains
US5413785A (en) * 1993-01-27 1995-05-09 New England Deaconess Hospital Corp. Methodology employing lactobacillus GG for reduction of plasma endotoxin levels circulating in-vivo
US6156320A (en) * 1993-02-05 2000-12-05 Harry Parsekian Fermented milk nutraceuticals
US6358521B1 (en) * 1993-02-05 2002-03-19 Harry Parsekian Fermented milk nutraceuticals
US5709857A (en) * 1994-05-26 1998-01-20 Dibra S.P.A. Lactobacillus strains of human origin, their compositons and uses thereof
US6506380B1 (en) * 1995-06-14 2003-01-14 Valio Oy Methods of preventing or treating allergies
US20030113340A1 (en) * 1995-06-14 2003-06-19 Valio Oy Methods of promoting tolerogenic immune responses and compositions therefor
US6007808A (en) * 1995-06-23 1999-12-28 Dibra S.P.A. Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders
US6942849B2 (en) * 1998-08-12 2005-09-13 Nestec S.A. Incorporation of exogenous lactic bacteria into the oral microflora
US6835376B1 (en) * 1999-03-11 2004-12-28 Nestec S.A. Lactobacillus paracasei strain for preventing diarrhea caused by pathogenic bacteria
US7029669B1 (en) * 1999-03-11 2006-04-18 Nestec S. A. Lactic acid bacteria strains capable of preventing diarrhoea
US6596530B1 (en) * 1999-06-24 2003-07-22 Meiji Dairies Corporation Strain of Lactobacillus gasseri
US20030161820A1 (en) * 1999-06-24 2003-08-28 Meiji Milk Products Company, Limited Food or drink product with a disinfection property of helicobacter pylori
US6926891B1 (en) * 1999-08-05 2005-08-09 Nestec S.A. Treatment of diarrhea with strains of Bifidobacterium longum
WO2001088510A2 (en) * 2000-05-18 2001-11-22 Argose, Inc. Pre-and post-processing of spectral data for calibration using multivariate analysis techniques
US20020028269A1 (en) * 2000-06-13 2002-03-07 Lipton, Division Of Conopco, Inc. Lactobacillus containing product
US20060013806A1 (en) * 2000-06-20 2006-01-19 Erika Isolauri Probiotics in primary prevention of atopic diseases
US7112322B2 (en) * 2000-06-20 2006-09-26 Erika Isolauri Probiotics in primary prevention of atopic diseases
US20040115773A1 (en) * 2001-01-30 2004-06-17 Fabrizio Arigoni Serpin in bifidobacteria
US7101565B2 (en) * 2002-02-05 2006-09-05 Corpak Medsystems, Inc. Probiotic/prebiotic composition and delivery method
US20030147857A1 (en) * 2002-02-05 2003-08-07 Corpak Medsystems, Inc. Probiotic/prebiotic composition and delivery method
US20040067573A1 (en) * 2002-10-07 2004-04-08 Eamonn Connolly Selection and use of lactic acid bacteria for reducing inflammmation caused by helicobacter
US20050002874A1 (en) * 2003-01-29 2005-01-06 Bo Mollstam Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries
US20050158254A1 (en) * 2003-01-29 2005-07-21 Bo Mollstam Use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries
US6872565B2 (en) * 2003-01-29 2005-03-29 Biogaia Ab Product containing Lactobacillus reuteri strain ATTC PTA-4965 or PTA-4964 for inhibiting bacteria causing dental caries
US20060165661A1 (en) * 2003-06-13 2006-07-27 N>V> Nutricia Pediocin-producing pediococci
US20070110849A1 (en) * 2003-06-23 2007-05-17 Marie-Christine Secretin Infant or follow-on formula
US20070269515A1 (en) * 2003-12-24 2007-11-22 Henriksen Kristian L Probiotic Tablet Formulations
US20070123460A1 (en) * 2004-04-20 2007-05-31 The University Of Chicago Probiotic compounds from Lactobacillus GG and uses therefor
US20090274661A1 (en) * 2006-02-15 2009-11-05 Nestec S.A. Use of bifidobacterium longum for the prevention and treatment of inflammation
US20080095752A1 (en) * 2006-10-20 2008-04-24 Win-Chin Chiang Method for extending the shelf-life of powdered nutritional formulations which contain viable probiotics
US20110020304A1 (en) * 2008-03-14 2011-01-27 Nestec S.A. Synbiotic mixture

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130259977A1 (en) * 2010-11-18 2013-10-03 Meiji Co., Ltd. Fermented milk with reduced sourness and method for producing same
US20160227828A1 (en) * 2015-02-05 2016-08-11 Abbott Laboratories Substantially clear nutritional liquids having improved sensory characteristics
US11606965B2 (en) 2016-05-11 2023-03-21 Chr. Hansen A/S Lactic acid bacteria for a heat-treated food product for storage at ambient temperature
WO2021048350A1 (en) 2019-09-12 2021-03-18 Chr. Hansen A/S Lactic acid bacteria for a heat-treated food product for storage at ambient temperature

Also Published As

Publication number Publication date
CN101273737A (en) 2008-10-01
CN101273738A (en) 2008-10-01
US10072310B2 (en) 2018-09-11
WO2008116355A1 (en) 2008-10-02
US20100009034A1 (en) 2010-01-14
WO2008116356A1 (en) 2008-10-02
CN101273736B (en) 2012-08-08
CN101273737B (en) 2011-08-24
CN101273738B (en) 2011-06-01
CN101273736A (en) 2008-10-01

Similar Documents

Publication Publication Date Title
US20100015285A1 (en) Process of preparing direct-acidified milk beverage keeping high viable cell count at ambient temperature
CA2753083C (en) Symbiotic maple product compositions and methods
KR101859992B1 (en) Cereals fermented by lactic acid bacteria and method for manufacturing the same
CN107873841B (en) Lactic acid bacteria beverage and production process thereof
CN103999935A (en) Post-acidification resistant fermented yogurt and preparation method thereof
CN106578064B (en) Donkey-hide gelatin and lactic acid bacteria beverage and preparation method thereof
TWI661775B (en) Fermented milk comprisingsaccharides comprising allulose, method of improving storability of fermented milk, and growth inhibitor for microorganisms
CN105982108B (en) Carrot juice beverage and preparation method thereof
US7326558B2 (en) Process for treating spirulina
CN101144064B (en) Lactobacillus brevis with anti-mutagenesis active and capable of producing exopolysaccharide and use thereof
JP5268916B2 (en) Acid lactic acid bacteria beverage, method for producing acid lactic acid bacteria beverage, and method for improving survival of bifidobacteria
CN110710627A (en) Functional probiotic solid beverage and preparation method thereof
KR20230001022A (en) A process for the preparation of sikhye containing lactobacillus and the sikhye containing lactobacillus prepared therefrom
RU2273662C2 (en) Consortium of microorganisms with probiotic effect
ES2250326T3 (en) CARBON ADDITIVE FOR FOOD FERMENTATIONS AND FOOD COMPOUNDS THAT CONTAIN IT.
CN104651262B (en) A kind of lactobacillus plantarum lyophilized preparation and its preparation method and application
CN109315693A (en) A kind of fermented sea buckthorn pudding and preparation method thereof
JP3925502B2 (en) Novel lactic acid bacteria, fermented soymilk obtained using the same, and method for producing the same
CN115152842A (en) Lactobacillus fermentum normal-temperature milk beverage and preparation method thereof
KR20100010556A (en) A method for preparing a herbal fermented functional liquid having a excellent sense effect and economical efficiency
KR102817171B1 (en) Lactic acid bacteria fermented beverage using ultra-fine red pepper powder and method for manufacturing the same
CN110574847A (en) Active fruit juice and preparation method thereof
Paliy et al. Influence of various prebiotic components on the main growth indicators of probiotic bacteria
KR20020033566A (en) Production process for foodstuff fermenting agents
KR101706842B1 (en) Bop-Sikhae and Manufacturing Method Thereof

Legal Events

Date Code Title Description
AS Assignment

Owner name: BEIJING YIHECUN TECH. CO., LTD.,CHINA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:LING, HAIBO;REEL/FRAME:023277/0335

Effective date: 20090912

STCB Information on status: application discontinuation

Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION